Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05838482 · ClinicalTrials.gov registry record
Clinical Feasibility and Evaluation of Silicon Photon Counting CT
A clinical trial of CT Photon-Counting, sponsored by GE Healthcare.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05838482: Recruiting study of CT Photon-Counting, sponsored by GE Healthcare.
NCT05838482 is a study of CT Photon-Counting that is actively recruiting participants, run by GE Healthcare. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05838482, a study of CT Photon-Counting, is actively recruiting participants, sponsored by GE Healthcare.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to collect data to evaluate utility of the using photon-counting CT in a clinical setting.
Primary Outcome
Number of Participants with raw investigational photon-counting CT scan data along with prior standard of care diagnostic CT exam data/images
Conditions Studied
Interventions
- DEVICE CT Photon-Counting
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-09-07 |
| Est. Completion | 2026-06 |
What NCT05838482 shows while recruiting
NCT05838482 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with CT Photon-Counting appearing as the primary indexed condition, and to 1 intervention - of which CT Photon-Counting is the first listed.
NCT05838482 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05838482 about?
NCT05838482 is a clinical study titled "Clinical Feasibility and Evaluation of Silicon Photon Counting CT". The purpose of the study is to collect data to evaluate utility of the using photon-counting CT in a clinical setting.
What is the current status of trial NCT05838482?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-09-07. Estimated completion is 2026-06.
What conditions does trial NCT05838482 study?
This clinical trial studies the following conditions: CT Photon-Counting.
What interventions are being tested in trial NCT05838482?
The interventions under investigation include: CT Photon-Counting (DEVICE).
Who is sponsoring clinical trial NCT05838482?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05838482 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI